115 related articles for article (PubMed ID: 38575390)
21. Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease.
Koçyiğit ÜM; Gezegen H; Taslimi P
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000202. PubMed ID: 32815568
[TBL] [Abstract][Full Text] [Related]
22. Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors.
Istrefi Q; Türkeş C; Arslan M; Demir Y; Nixha AR; Beydemir Ş; Küfrevioğlu ÖI
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900383. PubMed ID: 32285537
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel sulfamides incorporating phenethylamines and determination of their inhibition profiles against some metabolic enzymes.
Aksu K; Akıncıoğlu H; Akıncıoğlu A; Göksu S; Tümer F; Gülçin İ
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800150. PubMed ID: 30074266
[TBL] [Abstract][Full Text] [Related]
24. The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII).
Scozzafava A; Kalın P; Supuran CT; Gülçin İ; Alwasel SH
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):941-6. PubMed ID: 25586344
[TBL] [Abstract][Full Text] [Related]
25. The synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors.
Akıncıoğlu A; Kocaman E; Akıncıoğlu H; Salmas RE; Durdagi S; Gülçin İ; Supuran CT; Göksu S
Bioorg Chem; 2017 Oct; 74():238-250. PubMed ID: 28866249
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, characterization, molecular docking and biological activities of novel pyrazoline derivatives.
Turkan F; Cetin A; Taslimi P; Karaman HS; Gulçin İ
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800359. PubMed ID: 31125504
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of chalcone-imide derivatives and investigation of their anticancer and antimicrobial activities, carbonic anhydrase and acetylcholinesterase enzymes inhibition profiles.
Kocyigit UM; Budak Y; Gürdere MB; Ertürk F; Yencilek B; Taslimi P; Gülçin İ; Ceylan M
Arch Physiol Biochem; 2018 Feb; 124(1):61-68. PubMed ID: 28792233
[TBL] [Abstract][Full Text] [Related]
28. Discovery of sulfadrug-pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors.
Gümüş M; Babacan ŞN; Demir Y; Sert Y; Koca İ; Gülçin İ
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100242. PubMed ID: 34609760
[TBL] [Abstract][Full Text] [Related]
29. Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors.
Lolak N; Akocak S; Durgun M; Duran HE; Necip A; Türkeş C; Işık M; Beydemir Ş
Mol Divers; 2023 Aug; 27(4):1735-1749. PubMed ID: 36136229
[TBL] [Abstract][Full Text] [Related]
30. Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds.
Özgeriş B; Göksu S; Polat Köse L; Gülçin İ; Salmas RE; Durdagi S; Tümer F; Supuran CT
Bioorg Med Chem; 2016 May; 24(10):2318-29. PubMed ID: 27068142
[TBL] [Abstract][Full Text] [Related]
31. The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes.
Bayindir S; Caglayan C; Karaman M; Gülcin İ
Bioorg Chem; 2019 Sep; 90():103096. PubMed ID: 31284100
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of novel substituted thiophene derivatives and discovery of their carbonic anhydrase and acetylcholinesterase inhibition effects.
Cetin A; Türkan F; Taslimi P; Gulçin İ
J Biochem Mol Toxicol; 2019 Mar; 33(3):e22261. PubMed ID: 30537031
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in silico studies of triazene-substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors.
Bilginer S; Gul HI; Anil B; Demir Y; Gulcin I
Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000243. PubMed ID: 32984993
[TBL] [Abstract][Full Text] [Related]
34. Pyrazole[3,4-d]pyridazine derivatives: Molecular docking and explore of acetylcholinesterase and carbonic anhydrase enzymes inhibitors as anticholinergics potentials.
Taslimi P; Türkan F; Cetin A; Burhan H; Karaman M; Bildirici I; Gulçin İ; Şen F
Bioorg Chem; 2019 Nov; 92():103213. PubMed ID: 31470200
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and bioactivities of pyrazoline benzensulfonamides as carbonic anhydrase and acetylcholinesterase inhibitors with low cytotoxicity.
Ozmen Ozgun D; Gul HI; Yamali C; Sakagami H; Gulcin I; Sukuroglu M; Supuran CT
Bioorg Chem; 2019 Mar; 84():511-517. PubMed ID: 30605787
[TBL] [Abstract][Full Text] [Related]
36. Novel sulphamides and sulphonamides incorporating the tetralin scaffold as carbonic anhydrase and acetylcholine esterase inhibitors.
Akıncıoğlu A; Topal M; Gülçin I; Göksu S
Arch Pharm (Weinheim); 2014 Jan; 347(1):68-76. PubMed ID: 24243403
[TBL] [Abstract][Full Text] [Related]
37. The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity.
Aslan HE; Demir Y; Özaslan MS; Türkan F; Beydemir Ş; Küfrevioğlu ÖI
Drug Chem Toxicol; 2019 Nov; 42(6):634-640. PubMed ID: 29860891
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones.
Akıncıoğlu A; Akıncıoğlu H; Gülçin İ; Durdagi S; Supuran CT; Göksu S
Bioorg Med Chem; 2015 Jul; 23(13):3592-602. PubMed ID: 25921269
[TBL] [Abstract][Full Text] [Related]
39. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of some 1-naphthol derivatives as antioxidants, acetylcholinesterase, and carbonic anhydrase inhibitors.
Erdoğan M; Polat Köse L; Eşsiz S; Gülçin İ
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2100113. PubMed ID: 34080709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
